Filing Details
- Accession Number:
- 0000899243-19-012640
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-08 16:27:12
- Reporting Period:
- 2019-05-06
- Accepted Time:
- 2019-05-08 16:27:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1403752 | Zymeworks Inc. | ZYME | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1761857 | A Neil Klompas | C/O Zymeworks Inc. 1385 West 8Th Avenue, Suite 540 Vancouver A1 V6H 3V9 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-06 | 6,704 | $2.66 | 7,905 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-06 | 6,704 | $19.22 | 1,201 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 8,380 | $3.53 | 9,581 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-06 | 1,604 | $19.25 | 7,977 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2019-05-06 | 6,704 | $0.00 | 6,704 | $2.66 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2019-05-06 | 8,380 | $0.00 | 8,380 | $3.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-07-01 | 2019-07-01 | No | 4 | M | Direct |
| 0 | 2010-07-01 | 2019-06-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 700 | Indirect | Held by spouse |
Footnotes
- The exercise price of the stock option is CAD3.58. The U.S. dollar equivalent of the exercise price is $2.66 using the Bank of Canada exchange rate for May 6, 2019 (CAD1.00 = $0.7432).
- The shares were sold in multiple transactions and the price reported is a weighted average. The sale prices ranged from $19.07 to $19.48. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The exercise price of the stock option is CAD4.75. The U.S. dollar equivalent of the exercise price is $3.53 using the Bank of Canada exchange rate for May 6, 2019 (CAD1.00 = $0.7432).
- The shares were sold in multiple transactions and the price reported is a weighted average. The sale prices ranged from $19.13 to $19.365. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of July 1, 2007, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
- Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of July 1, 2009, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
Billionaire Hedge Funds
